Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

raymond-james-upgrades-verisk-analytics-(vrsk)-to-strong-buy-march-2026

Raymond James Upgrades Verisk Analytics (VRSK) to Strong Buy March 2026

Mar 3, 2026

Raymond James upgraded Verisk Analytics, Inc. (VRSK) to Strong Buy on March 2, 2026, marking the most notable…

Read more
jefferies-upgrades-vac-marriott-vacations-worldwide-corporation-to-buy-mar-2026

Jefferies upgrades VAC Marriott Vacations Worldwide Corporation to Buy Mar 2026

Mar 3, 2026

Jefferies upgraded Marriott Vacations Worldwide Corporation (VAC) to a Buy on March 02, 2026. This VAC analyst rating…

Read more
craig-hallum-starts-body-(the-beachbody-company,-inc.)-at-buy-march-02,-2026

Craig-Hallum starts BODY (The Beachbody Company, Inc.) at Buy March 02, 2026

Mar 3, 2026

Craig-Hallum started initial coverage of BODY at Buy on March 02, 2026. This BODY analyst rating marks a…

Read more
piper-sandler-maintains-overweight-on-pgr-(the-progressive-corporation)-mar-2026

Piper Sandler Maintains Overweight on PGR (The Progressive Corporation) Mar 2026

Mar 3, 2026

Piper Sandler maintained an Overweight rating on PGR (The Progressive Corporation) on March 2, 2026. This PGR analyst…

Read more
benchmark-maintains-buy-on-shift4-payments-(four),-pt-cut-to-$67-mar-2026

Benchmark Maintains Buy on Shift4 Payments (FOUR), PT Cut to $67 Mar 2026

Mar 3, 2026

Benchmark maintained a Buy rating on Shift4 Payments, Inc. (FOUR) and lowered its price target to $67 on…

Read more
rbc-capital-maintains-outperform-on-marvell-technology,-inc.-(mrvl)-mar-2026

RBC Capital Maintains Outperform on Marvell Technology, Inc. (MRVL) Mar 2026

Mar 3, 2026

RBC Capital maintained an Outperform rating on Marvell Technology, Inc. (MRVL) on March 2, 2026. This MRVL analyst…

Read more
rbc-maintains-sector-perform-on-avgop-broadcom-inc-mar-2026-pt-$340

RBC Maintains Sector Perform on AVGOP Broadcom Inc Mar 2026 PT $340

Mar 3, 2026

On March 02, 2026, RBC Capital maintained a Sector Perform rating on Broadcom Inc. (AVGOP), the latest entry…

Read more
piper-sandler-maintained-neutral-on-the-trade-desk,-inc.-(ttd)-march-2026

Piper Sandler Maintained Neutral on The Trade Desk, Inc. (TTD) March 2026

Mar 3, 2026

Get analyst ratings, AI forecasts, and market updates in your inbox every morning. 12% average open rate and…

Read more
should-bullish-analyst-coverage-on-bbu’s-valuation-reframe-how-investors-read-brookfield-business-partners’-dealmaking-ambitions?

Should Bullish Analyst Coverage on BBU’s Valuation Reframe How Investors Read Brookfield Business Partners’ Dealmaking Ambitions?

Mar 3, 2026

In recent days, CIBC initiated coverage on Brookfield Business Partners L.P. with an Outperformer rating, joining other brokers…

Read more
rbc-maint-regn-(regeneron-pharmaceuticals,-inc.)-at-sector-perform,-pt-$765-mar-2026

RBC Maint. REGN (Regeneron Pharmaceuticals, Inc.) at Sector Perform, PT $765 Mar 2026

Mar 3, 2026

RBC Capital maintained REGN at Sector Perform on Mar 02, 2026. The firm raised its price target to…

Read more
guggenheim-maintained-buy-on-united-parks-&-resorts-inc.-(prks)-march-2026

Guggenheim Maintained Buy on United Parks & Resorts Inc. (PRKS) March 2026

Mar 3, 2026

Get analyst ratings, AI forecasts, and market updates in your inbox every morning. 12% average open rate and…

Read more
bmo-maintains-outperform-on-vrtx,-vertex-pharmaceuticals-incorporated-mar-2026

BMO Maintains Outperform on VRTX, Vertex Pharmaceuticals Incorporated Mar 2026

Mar 3, 2026

BMO Capital maintained an Outperform rating and raised the price target to $600 for Vertex Pharmaceuticals Incorporated on…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 19
  6. 20
  7. 21
  8. 22
  9. 23
  10. 24
  11. 25
  12. ...
  13. 377
  14. »

Posts pagination

Newer posts Page 1 … Page 22 … Page 377 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.